Eric B. Gordon

Eric B. Gordon Email and Phone Number

Fractional or Interim CFO & COO Partner – Driving Profitable Growth of Venture Backed Biotech and Healthcare Related Businesses @
Eric B. Gordon's Location
Boston, Massachusetts, United States, United States
Eric B. Gordon's Contact Details

Eric B. Gordon personal email

About Eric B. Gordon

I am a CFO, COO & Operating Partner with a proven track record of developing the right strategy, plans, and resources that meet growth and profitability objectives of venture-backed biotech and healthcare-related businesses. I have a passion for assessing emerging technologies, developing strategy, and executing on agile plans with limited resources. I have successfully worked and built management teams and the resources that develop, manufacture, and market prescription medicines and digital therapeutics, vaccines, diagnostics, medical devices and drug discovery platforms toward $B valuations. I possess a strong knowledge in designing and building Healthcare AI applications and completing Healthcare Economics and Outcomes Research (HEOR).► Built 8 Start-Ups in Digital Therapeutics, Behavioral Healthcare, Medical Device, Health Tech, Drug Discovery and Delivery, Vaccines, SaaS, and Consumer Products. Two exited at $B+ valuations and twice “returned the entire fund” for VCs.► Championed the exit of 8 healthcare-related businesses totaling $4B in transaction price for up to 55X ROI and 40X EBIDTA, including two unicorns, one was a $2.7B exit to Merck, the other was a $.9B exit to now Sanofi.► Raised $1.4B in capital/debt from lead bankers such as JP Morgan Chase, Oppenheimer, and others as well as $209M in equity, including 2 IPOs totaling ~$129M and 10 seed/venture rounds for $80M.► Closed 41 high-profile SaaS subscription deals $660M cash, including Pfizer, Roche, Novartis, Abbott, Wyeth, Takeda, Solvay, Millennium, Human Genome Sciences.► Co-led 11 FDA vaccine approvals and 1 FDA medical device clearance. ► Lead responsibility for P&L’s that met growth and profitability objectives exceeding $775M revenues delivering 30%+ operating margins, and co-led two mergers and sales totaling $1B+, including co-responsibility for broad-scale American and European integration.CORE COMPETENCIES:Extensive accounting, finance, tax and reporting and experience. Strong business, data analytics and preparation of financial forecasts. Collaboration, communication, interpersonal and managerial skills. Stategic planning, decision making, plan execution and innovative problem solving. Systems architecture, planning, management and implementation. Investor communications and relations and Board of Directors management. Capital and debt acquisition. Organizational design, formation, and human resource development. Clinical product development, study design, regulatory licensing and compliance - FDA, FTC, Quality. Negotiation and deal closure.

Eric B. Gordon's Current Company Details
Eric Gordon Consulting LLC

Eric Gordon Consulting Llc

Fractional or Interim CFO & COO Partner – Driving Profitable Growth of Venture Backed Biotech and Healthcare Related Businesses
Eric B. Gordon Work Experience Details
  • Eric Gordon Consulting Llc
    Fractional And Interim Cfo & Coo
    Eric Gordon Consulting Llc May 2023 - Present
    • Providing CFO and COO consulting services for biotech and healthcare companies in Greater Boston, advising on corporate finance, M&A, capital raise, BOD, and strategic planning.• Partnering with management teams to accelerate drug discovery and digital health technologies from innovation to commercialization.• Delivering successful implementation of strategic operating systems resulting in streamlined processes and increased efficiency.
  • Translational Ventures
    Managing Partner
    Translational Ventures Jul 2003 - 2022
    Identified, developed and scaled promising medical technologies with investigators from Harvard, MIT, and Duke tech transfer offices. With investigator, managed technology and product strategy, planning, execution, seed and venture capital funding, team and resource development, and all finance and legal-related matters. Spearheaded introductions, feasibility, and selection from >500 emerging medical technologies and negotiated/executed licensing contracts with all stakeholders to complete build-out plans, and obtain financial and resource commitments. Company 1: Atentiv Health - CEO, CFO, Chairman - Launched Virtually Delivered Digital Therapeutic for the Treatment of ADHD• Founded, seeded, discovered, developed, and launched, in partnership with Duke University at NJ’s largest RWJBarnabas Health system. Raised $19M. Sold.Company 2: BioBehavioral Diagnostics – CEO, CFO, Chairman – Launched FDA-Cleared Digital Diagnostic for Treatment of ADHD• Co-founded, seeded, discovered, developed, and launched, in partnership with Harvard Medical School, Raised $8M. Achieved FDA marketing clearance. Led growth to $12M ARR. Sold.Company 3: Combinent BioMedical Systems – CEO, CFO, Chairman – Successful POC Efficacy of Novel Endometriosis Treatment• Co-founded and seeded, in partnership with MIT (Dr. Bob Langer) and Harvard Medical School. Raised $5M. Sold.Company 4: Cardium Pharmaceuticals – CEO, CFO, Chairman – Completed inconclusive POC for an HDL Therapeutic . • Co-founded and seeded, in partnership with MIT. Raised $3.1M. Sold.
  • Ardais Corporation
    Ceo, Cfo & Chairman
    Ardais Corporation 1999 - 2002
    Us
    Built Market-Ready Drug Target Discovery Platform to Meet Emerging Demand for High-throughput Screening Platforms. • Conceptualized, founded, seeded, developed, and launched the first clinical (digital) genomics analysis platform that enabled significantly higher quality drug target identification for drug discovery in high-throughput assays. • Developed a unique subscription-based business model that enabled free acquisition of high-quality diseased samples and associated health data from leading medical research institutions including Duke, Harvard, Yale, Chicago, and others to create highly valuable repository of clinical, pathologic, and genomic data for structured data analyses and potential drug target identification. • Raised $34M. Sold.
  • Arqule
    Ceo & President
    Arqule Oct 1995 - Dec 1999
    Built and Commercialized Proprietary Drug Discovery Platform that became Pharma Industry Standard in Drug Discovery. With investigator, grew from a theoretical concept to ~$1B NASDAQ market cap.• Led strategy, product, manufacturing, business development and capital financing to the market leading combinatorial chemistry drug discovery technology platform.• Initiated and completed $49M IPO and $49M follow-on financing ($325M post), culminating in $.9B market cap. Reached $65M ARR on an evergreen SaaS model. Forever changed the pharmaceutical industry drug discovery chemistry platform to high-speed synthesis and screening. • Completed 41 pharmaceutical and biotech SaaS subscription agreements totaling $660M with leading healthcare companies including Pfizer, Roche, Novartis, Abbott, Takeda, Wyeth, Solvay, Millenium, Human Genome Sciences (in less than 18 months). • Subsequently, discovered and developed a blood cancer BTK inhibitor drug through Ph III. • Sold to Merck for $2.7B.
  • Pasteur Merieux Connaught (Now Sanofi Pasteur)
    Svp And Chief Financial Officer/ Corporate Treasurer
    Pasteur Merieux Connaught (Now Sanofi Pasteur) 1985 - 1995
    Co-developed, Built and Managed Commercialization from $3M to $550M ARR. Joined co-founders to start-up (restart) an abandoned pediatric vaccine manufacturing facility with early FDA-approved vaccines. • Grew the company from $3M in to $550M+ revenue in 7 years with only $5M infused from investors. • Developed the initial strategy and fully participated in the passage of the “National Vaccine Compensation Act” by Congress. • Co-led 2nd public offering with US team and closed $31M in financing from Canadian banks. • Co-negotiated/closed a $280M co-marketing deal with Merck. • Co-managed a ~$1B sale to Pasteur Merieux followed by co-managing the merger in Lyon, France.
  • Virogenetics
    Ceo And Cfo
    Virogenetics 1990 - May 1994
    Co-developed and Successfully Completed Novel Malaria Vaccine Proof of Concept.• Led start-up team and co-managed development of the first successful “4-stage” Malaria vaccine on a novel delivery system that has since effectively treated tens of millions of people. • Raised $4M. Sold to Pasteur-Merieux for $64M.
  • Sterling Drug
    Vp Chief Financial Officer; Sterling Drug, General Mgr. - Glenbrook Labs Otc Products Division
    Sterling Drug 1980 - 1985
    • Led financial planning, analysis, SEC reporting and investor relations for a $6.5B Fortune 500 pharmaceutical company and was promoted to General Manager of the global OTC products Company, Glenbrook Labs. • Held full P&L responsibility for $775 in revenue and 40% operating margin with products including Bayer Aspirin, Panadol, Philips Milk of Magnesia, Stridex, Midol, Vanquis, and more. • Achieved 22% revenue increase and 25% profitability increase in three years with no capital investment. • Also co-managed the OTC product manufacturing division - 7 sites. • Sold to Kodak.
  • Arthur Andersen & Co.
    Senior Manager
    Arthur Andersen & Co. 1972 - 1980
    Tax, Audit, pharmaceutical M&A consulting.

Eric B. Gordon Skills

Executive Management Start Ups Clinical Research Corporate Development Drug Discovery Pharmaceutical Industry Innovation Management Biotechnology

Eric B. Gordon Education Details

  • The Wharton School
    The Wharton School
    International Finance
  • Syracuse University - Martin J. Whitman School Of Management
    Syracuse University - Martin J. Whitman School Of Management
    Finance Accounting

Frequently Asked Questions about Eric B. Gordon

What company does Eric B. Gordon work for?

Eric B. Gordon works for Eric Gordon Consulting Llc

What is Eric B. Gordon's role at the current company?

Eric B. Gordon's current role is Fractional or Interim CFO & COO Partner – Driving Profitable Growth of Venture Backed Biotech and Healthcare Related Businesses.

What is Eric B. Gordon's email address?

Eric B. Gordon's email address is er****@****ail.com

What schools did Eric B. Gordon attend?

Eric B. Gordon attended The Wharton School, Syracuse University - Martin J. Whitman School Of Management.

What skills is Eric B. Gordon known for?

Eric B. Gordon has skills like Executive Management, Start Ups, Clinical Research, Corporate Development, Drug Discovery, Pharmaceutical Industry, Innovation Management, Biotechnology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.